financetom
Business
financetom
/
Business
/
Trimas Insider Bought Shares Worth $9,156,434, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Trimas Insider Bought Shares Worth $9,156,434, According to a Recent SEC Filing
May 26, 2025 12:08 PM

05:51 PM EDT, 05/21/2025 (MT Newswires) -- Shawn Sedaghat, 10% Owner, Director, on May 19, 2025, executed a purchase for 359,357 shares in Trimas ( TRS ) for $9,156,434. Following the Form 4 filing with the SEC, Sedaghat has control over a total of 5,575,456 common shares of the company, with 4,174,807 shares held directly and 1,400,649 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/842633/000084263325000092/xslF345X05/wk-form4_1747864036.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cue Biopharma Enters License Deal With ImmunoScape for Next-Generation Cell Therapy for Solid Tumors
Cue Biopharma Enters License Deal With ImmunoScape for Next-Generation Cell Therapy for Solid Tumors
Nov 13, 2025
02:02 PM EST, 11/13/2025 (MT Newswires) -- Cue Biopharma ( CUE ) entered an exclusive licensing deal giving ImmunoScape access to its clinical-stage Immuno-STAT molecules for oncology, ImmunoScape said Thursday. The deal includes a total upfront payment of $15 million, with $10 million in fiscal Q4 and $5 million in November 2026, and gives Cue Biopharma ( CUE ) a...
Novo Nordisk, Lilly deny partnership with Mangoceuticals on obesity drugs
Novo Nordisk, Lilly deny partnership with Mangoceuticals on obesity drugs
Nov 13, 2025
Nov 13 (Reuters) - Novo Nordisk and Eli Lilly ( LLY ) do not have a weight-loss drug partnership with telehealth website Mangoceuticals Inc ( MGRX ), spokespeople for both companies said, rejecting a press release issued by the company on Thursday that described arrangements with the two leading drugmakers. Spokespeople for both companies said in emails to Reuters that...
60 Degrees Pharma Q3 net product revenue rises
60 Degrees Pharma Q3 net product revenue rises
Nov 13, 2025
Overview * 60 Degrees Pharmaceuticals ( SXTP ) Q3 net product revenue up 223% yr/yr to $438 thousand * Company reports Q3 gross loss of $100 thousand due to inventory write-off * Operating expenses rose to $2.32 mln in Q3, driven by higher advertising costs Outlook * Company did not provide specific financial guidance for future quarters or full year...
Why Is Ballard Power Systems Stock Plunging Today?
Why Is Ballard Power Systems Stock Plunging Today?
Nov 13, 2025
Ballard Power Systems Inc. ( BLDP ) shares are trading lower on Thursday after the company reported third-quarter FY25 earnings results. BLDP is encountering selling pressure. Get the market research here Ballard Power ( BLDP ) reported a net loss from continuing operations of $28.1 million, or 9 cents per share, beating Wall Street expectations for a loss of 11 cents per...
Copyright 2023-2026 - www.financetom.com All Rights Reserved